S&P 500
(-0.02%) 5 420.05 points
Dow Jones
(-0.38%) 38 566 points
Nasdaq
(0.07%) 17 622 points
Oil
(0.32%) $78.75
Gas
(-2.79%) $2.96
Gold
(-1.56%) $2 318.10
Silver
(-4.20%) $29.00
Platinum
(-1.51%) $956.30
USD/EUR
(0.72%) $0.931
USD/NOK
(0.78%) $10.65
USD/GBP
(0.39%) $0.784
USD/RUB
(-0.70%) $88.37

Realtime updates for Allogene Therapeutics Inc [ALLO]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated13 Jun 2024 @ 13:22

-0.19% $ 2.57

Live Chart Being Loaded With Signals

Commentary (13 Jun 2024 @ 13:22):
Our systems believe the stock currently is undervalued by 8 090.44% compare to its pairs and should correct upwards.

Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer...

Stats
Today's Volume 764 184
Average Volume 2.49M
Market Cap 535.53M
EPS $-0.380 ( Q1 | 2024-05-13 )
Next earnings date ( $-0.360 ) 2024-08-07
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.440
(Sector) 42.63
(Industry) 24.32
ATR14 $0.00600 (0.23%)
AADI 1.77%
ABCL -2.49%
ABCM 0.04%
ABEO 2.67%
ABIO -0.90%
ABOS -0.56%
ABSI -9.07%
ABUS -3.23%
ABVX -3.23%
ACAD -1.43%
ACER -17.95%
ACET 4.29%
ACGN 1.29%
ACHL -0.76%
ACHV -2.49%
ACIU 2.16%
ACLX 0.84%
ACRV 0.86%
ACST -0.31%
ACXP -1.61%
ADAG -3.61%
ADAP 0.48%
ADGI 0.87%
ADIL -1.49%
ADMA -0.79%
ADPT -3.90%
ADTX -9.90%
ADVM -3.30%
ADXN -2.48%
AEON -3.97%
AEZS -2.80%
AFMD 1.82%
AGEN -3.90%
AGIO -1.10%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -34.07%
AKBA -3.88%
AKRO 0.25%
AKTX -4.89%
AKUS 0.00%
ALBO 0.00%
ALDX 0.26%
ALEC 2.34%
ALGS 0.19%
ALKS -0.48%
ALLK -3.91%
ALLO -0.19%
ALLR -8.53%
ALNA 3.16%
ALNY -0.14%
ALPN 0.00%
ALPX 0.00%
ALRN 0.00%
ALT 2.59%
ALVR -1.72%
ALXN 0.00%
ALXO -1.29%
ALZN 2.04%
AMRN -2.17%
AMTI -3.13%
ANAB -0.71%
ANEB -4.52%
ANGN 0.00%
ANIX 2.27%
ANL -3.83%
ANNX 0.66%
ANPC -3.15%
APGE -4.50%
APGN 8.48%
APGNW 30.65%
APLM -5.35%
APLS -0.40%
APLT -0.38%
APM 1.78%
APOP 0.38%
APRE -3.14%
APTO 2.27%
APTX 3.17%
APVO -3.40%
ARAV -13.39%
ARCT 2.45%
ARDS 0.00%
ARDX -3.81%
ARGX 1.29%
ARNA 0.00%
ARPO -0.90%
ARQT 7.22%
ARTL 1.95%
ARTLW -1.43%
ARVN 0.64%
ARWR 1.94%
ASLN -1.67%
ASMB -0.79%
ASND -1.00%
ATAI 2.65%
ATHA -1.54%
ATHE -3.39%
ATHX -33.50%
ATNF 3.82%
ATOS -3.15%
ATRA -4.64%
ATXI 1.35%
ATXS -1.51%
AUPH -1.74%
AURA -0.28%
AUTL 1.04%
AVBP -0.32%
AVEO 0.00%
AVIR -1.19%
AVRO -1.33%
AVTE 3.15%
AVTX 0.87%
AVXL -1.73%
AXLA 0.00%
AXSM -1.19%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 1.38%
BCAB -2.22%
BCDA -1.93%
BCDAW 0.00%
BCEL 0.22%
BCLI -3.05%
BCRX -1.71%
BCTX 3.05%
BCTXW 0.00%
BCYC -1.14%
BDRX -1.48%
BDTX -2.24%
BEAM -1.63%
BFRA -2.91%
BGNE -1.11%
BIOR 1.34%
BIVI -1.26%
BLCM -6.68%
BLI -5.88%
BLPH 2.42%
BLRX -1.29%
BLTE 0.05%
BLU 0.03%
BLUE 1.65%
BMEA 23.97%
BMRN -0.77%
BNOX 16.47%
BNTC -0.84%
BNTX -2.30%
BOLD -10.62%
BOLT 0.57%
BPMC 1.04%
BPTH -1.88%
BPTS -13.47%
BRNS -1.06%
BRTX 28.36%
BTAI -3.77%
BTTX -12.22%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 6.94%
CABA -0.08%
CADL -0.92%
CALA -37.50%
CALC -0.40%
CALT -0.43%
CAPR 4.55%
CARA -35.44%
CARM 4.27%
CASI -5.59%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 0.51%
CCCC -2.52%
CCXI 0.00%
CDAK 0.00%
CDIO 0.53%
CDIOW 3.62%
CDMO -7.49%
CDMOP 0.04%
CDT -3.49%
CDTTW -47.95%
CDTX -2.23%
CDXC 5.28%
CDXS -5.76%
CELC 3.40%
CELU -2.16%
CELUW -13.31%
CERC -1.68%
CERE 0.68%
CERO -36.66%
CEROW 13.07%
CFRX -27.95%
CGEM 0.97%
CGEN 0.49%
CGON -1.39%
CGTX -3.99%
CHMA -6.00%
CHRS -3.02%
CINC 0.00%
CING -1.53%
CINGW -8.54%
CKPT 2.42%
CLBS -16.75%
CLDX 0.67%
CLGN -1.87%
CLLS -5.37%
CLNN -1.09%
CLNNW -37.22%
CLRB 1.50%
CLSD 3.20%
CLSN -0.68%
CLVS 0.00%
CMMB 1.83%
CMND -2.80%
CMPI 0.00%
CMPX -2.51%
CMRA 0.40%
CMRAW 0.00%
CMRX -3.06%
CNCE 0.00%
CNSP 9.90%
CNST 0.00%
CNTA 1.24%
CNTB -5.53%
CNTX -2.50%
COCP -4.29%
COEPW -23.50%
COGT -1.55%
CORT -4.42%
COYA -6.55%
CPRX -0.87%
CRBP 4.88%
CRBU -2.28%
CRDF -1.69%
CRGX -0.58%
CRIS -3.41%
CRNX -0.94%
CRSP 0.55%
CRTX 2.63%
CRVO 5.02%
CRVS 1.93%
CSBR -4.05%
CTCX 7.00%
CTIC 0.06%
CTMX -3.02%
CTNM 0.54%
CTXR -2.59%
CUE 4.00%
CVAC -4.09%
CVKD -3.04%
CWBR 0.00%
CYAD -12.96%
CYCC 0.58%
CYCCP -1.79%
CYCN -20.16%
CYT -2.27%
CYTK -0.15%
CYTO -2.32%
DARE -4.22%
DAWN -2.08%
DBTX -0.81%
DBVT -1.90%
DFFN 10.28%
DICE 0.06%
DMAC -4.78%
DNLI 1.93%
DNTH 3.14%
DOMH 0.93%
DRMA 15.28%
DRMAW 0.00%
DRNA 0.00%
DRTS 0.00%
DRTSW 1.84%
DRUG 1.87%
DSGN 0.40%
DTIL -0.30%
DYAI 4.31%
EARS -1.77%
EDIT -6.37%
EDSA -1.45%
EFTR 3.70%
EFTRW -47.95%
EIGR 0.00%
ELAB -1.25%
ELDN 0.68%
ELEV -0.60%
ELOX 0.00%
ELTX -0.47%
ELVN -1.76%
ELYM -2.94%
ENGN 0.20%
ENGNW 2.35%
ENLV -0.71%
ENOB 1.79%
ENSC -2.87%
ENTA 0.00%
ENTO 4.65%
ENTX -6.38%
ENVB 1.08%
EPIX -5.47%
EPRX -1.47%
EPZM 0.00%
EQ 1.27%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.35%
ERNA -1.79%
ERYP 1.30%
ESLA 4.24%
ESLAW -13.23%
ETNB -0.43%
ETON -0.41%
ETTX 0.00%
EVAX -2.79%
EVGN -1.09%
EVLO 50.00%
EWTX -0.84%
EXAI -4.73%
EXEL -0.34%
EYEG 0.46%
EYEN -1.63%
EYPT -2.15%
FATE 0.13%
FBIO -1.26%
FBIOP 0.00%
FBLG 0.52%
FBRX 1.63%
FDMT 0.25%
FENC 0.15%
FGEN -2.16%
FHTX -3.73%
FIXX 0.77%
FMTX 0.00%
FNCH 11.94%
FOLD 0.14%
FREQ 4.76%
FRLN 0.15%
FRTX -3.74%
FSTX 0.00%
FTRE -1.53%
FULC -0.26%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -1.84%
GANX -12.33%
GBIO 1.97%
GBT 0.01%
GDTC 0.00%
GERN -4.03%
GHRS 2.66%
GLMD 5.85%
GLPG -1.46%
GLSI 3.36%
GLTO -0.49%
GLUE -2.16%
GLYC 3.19%
GMAB -1.53%
GMDA 0.00%
GMTX 0.00%
GNCA -85.71%
GNFT -3.17%
GNLX -1.25%
GNPX -3.93%
GNTA -4.55%
GOSS 0.19%
GOVX -6.04%
GOVXW 2.25%
GPCR -0.85%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -3.31%
GRTX -1.80%
GTHX 3.74%
GUTS -2.46%
GXGXW 41.67%
GYRE 2.92%
HALO -0.97%
HARP 0.09%
HCWB 8.95%
HEPA -2.55%
HGEN -84.62%
HILS 5.66%
HLVX 0.48%
HOOK -0.38%
HOTH -3.80%
HOWL 6.84%
HRMY 0.25%
HRTX -1.01%
HSTO -38.33%
HUMA -3.81%
HUMAW -1.75%
IBRX 2.32%
ICCC -0.93%
ICPT 0.21%
ICU -4.28%
ICUCW 1.15%
ICVX -0.91%
IDRA -23.04%
IDYA -0.61%
IFRX -5.66%
IGMS -4.12%
IKNA -0.29%
IKT -2.29%
IMAB -0.54%
IMCR -1.93%
IMGN 0.02%
IMGO 0.00%
IMMP 6.64%
IMMX -3.34%
IMNM -0.69%
IMNN -0.83%
IMPL -27.27%
IMRA 15.96%
IMRN -1.75%
IMRX 10.39%
IMTX -0.72%
IMTXW -1.45%
IMUX -0.79%
IMV 0.00%
IMVT 0.96%
INAB 14.77%
INBX 0.61%
INCY 3.50%
INDP -3.27%
INFI -52.38%
INKT -0.42%
INM -3.38%
INMB 1.49%
INO 0.95%
INSM 0.74%
INTS -0.41%
INVA 0.66%
INZY -3.50%
IOBT 0.00%
IONS -0.22%
IOVA -2.87%
IPA 1.92%
IPHA -3.07%
IPSC -2.45%
IRON -0.57%
ISEE 0.38%
ITOS -2.37%
ITRM -1.66%
IVA -4.29%
IVVD 3.33%
JAGX -2.03%
JANX 0.80%
JAZZ 1.51%
JNCE 0.00%
JSPR 1.67%
JSPRW -22.19%
JUNS 0.00%
JUNSW 0%
KA 2.17%
KALV -1.54%
KDNY 0.22%
KMPH -0.34%
KNSA -2.27%
KNTE -0.38%
KOD -1.79%
KPRX -3.13%
KPTI -0.97%
KRBP 3.59%
KRON -15.63%
KROS 0.33%
KRRO 0.66%
KRTX 0.03%
KRYS 0.29%
KTRA -2.43%
KTTA -4.76%
KTTAW -27.22%
KURA -1.71%
KYMR -0.77%
KYTX 4.29%
KZIA -3.56%
KZR -2.99%
LABP 0.57%
LBPH 2.95%
LBPS 0.00%
LBPSW 14.81%
LEGN -4.03%
LENZ -1.12%
LEXX 6.48%
LEXXW 10.53%
LGND 0.12%
LGNDV 0.00%
LGVN 75.14%
LIAN 0.00%
LIFE 2.70%
LIPO 4.60%
LIXT -1.74%
LIXTW -28.42%
LJPC -0.32%
LMNL 0.12%
LOGC 0.09%
LPCN 0.63%
LPTX -1.15%
LQDA -0.83%
LRMR 0.31%
LSTA 1.74%
LTRN -4.25%
LUMO 1.39%
LVTX 5.24%
LXEO 3.63%
LXRX -3.67%
LYEL -0.20%
LYRA -1.90%
MACK 0.00%
MBIO -7.32%
MBRX 2.31%
MCRB -3.21%
MDGL -1.65%
MDNA -13.16%
MDWD 0.00%
MDXG -3.91%
MEIP 1.05%
MESO 0.14%
MGNX -4.41%
MGTA -7.74%
MGTX -1.92%
MGX 1.98%
MIRM -0.93%
MIRO 0.59%
MIST -0.70%
MITO 0.00%
MLEC 0.00%
MLECW 0.00%
MLND -5.36%
MLTX -0.64%
MLYS 0.87%
MNKD 4.86%
MNMD 2.29%
MNOV 0.74%
MNPR -4.49%
MOLN -1.55%
MOR -0.11%
MORF -2.96%
MREO 4.18%
MRKR -0.76%
MRNA -1.49%
MRNS -1.67%
MRSN -1.76%
MRTX -0.17%
MRUS -0.26%
MRVI -0.82%
MTCR -1.29%
MTEM -6.99%
MTP -18.50%
MURA -2.95%
MYMD 2.45%
NAMS -0.51%
NAMSW -2.24%
NAUT -5.67%
NBRV 0.71%
NBSE -1.56%
NBTX -3.27%
NCNA -0.33%
NERV 1.54%
NEXI -0.26%
NGM -1.28%
NGNE 8.71%
NKGN 1.55%
NKGNW 5.88%
NKTR -1.55%
NKTX -0.79%
NLSP -6.02%
NLSPW 61.29%
NMRA 1.70%
NMTR -42.97%
NOVN -24.84%
NRBO 0.82%
NRIX 1.52%
NRSN -1.76%
NRSNW 9.14%
NRXP 1.55%
NRXPW 45.50%
NRXS 7.51%
NTBL 2.15%
NTEC -12.45%
NTHI 0%
NTLA -0.39%
NTRBW -23.58%
NUVL -0.82%
NVAX -3.71%
NVCT 2.26%
NVIV -34.28%
NXTC 7.53%
NYMX -0.05%
OABI -4.43%
OABIW 6.52%
OBIO -0.50%
OBSV 0.00%
OCEA 0.00%
OCGN -1.31%
OCS -0.03%
OCUL -0.91%
OCUP -2.78%
ODT -4.27%
OKYO 2.66%
OLMA -1.86%
OMER 7.68%
OMGA -1.90%
ONCO -7.74%
ONCR -3.08%
ONCS 31.87%
ONCT 4.35%
ONCY -0.97%
ONTX -0.47%
ONVO -0.37%
OPNT 0.00%
OPT -0.79%
ORGS 9.60%
ORIC -3.80%
ORMP -0.43%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK 1.72%
OVID -2.18%
OYST 0.00%
PALI -0.63%
PASG 2.91%
PBLA 0.03%
PBM -2.90%
PBYI -5.56%
PCSA -3.13%
PCVX 0.17%
PDSB 3.24%
PEPG -2.48%
PGEN 0.00%
PHAR 0.12%
PHAS 0.00%
PHAT -0.55%
PHIO 0.13%
PHIOW 36.47%
PHVS -1.37%
PHXM -5.20%
PIRS 0.30%
PKBO 0.00%
PKBOW 0.00%
PLRX 0.09%
PLUR 0.18%
PMN 2.39%
PMVP -3.67%
PNT 0.16%
PPBT 2.31%
PRAX -2.07%
PRDS 0.93%
PRLD -4.22%
PROG -3.47%
PROK -0.83%
PRQR 0.00%
PRTA -1.86%
PRTC -0.13%
PRTG -1.24%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -3.20%
PSTX -0.36%
PTCT -1.81%
PTE -0.82%
PTGX 0.76%
PTIXW 0.00%
PULM -0.53%
PXMD -7.66%
PYPD -1.57%
PYXS 0.65%
QLGN -2.95%
QNCX -2.79%
QNRX 1.39%
QSI -4.28%
QSIAW 0.00%
QTTB 0.52%
QURE -1.14%
RAIN -1.63%
RANI 2.25%
RAPT -3.24%
RARE -4.37%
RCKT -0.31%
REGN -0.55%
RENB 0.70%
REPL 6.69%
RETA 0.02%
REUN -0.89%
REVB 3.56%
REVBU 3.46%
REVBW 1.44%
RGLS 4.86%
RGNX -3.80%
RIGL -0.96%
RLAY -2.04%
RLMD -0.99%
RLYB 1.52%
RNA 4.16%
RNAC -4.39%
RNAZ -5.76%
RNXT -5.98%
ROIV -0.46%
ROIVW 4.56%
RPHM -1.72%
RPRX 0.46%
RPTX -0.50%
RUBY 2.70%
RVLP -32.05%
RVMD -1.00%
RVMDW 3.82%
RVNC 1.32%
RVPH -1.32%
RVPHW 19.23%
RXDX 0.09%
RXRX 0.04%
RYTM 2.74%
RYZB 0.02%
RZLT -5.47%
SABS 2.81%
SABSW -18.90%
SAGE 3.23%
SANA 2.64%
SAVA 0.84%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 16.54%
SCPH -0.50%
SCPS 0.00%
SEEL -4.59%
SEER -1.88%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -7.87%
SGMT -5.78%
SGTX -2.56%
SIOX 22.63%
SLDB 8.83%
SLGL 1.12%
SLN -3.75%
SLNO -2.22%
SLRX 0.18%
SLS -0.80%
SMMT -0.36%
SNDX 1.50%
SNGX 21.22%
SNPX -1.60%
SONN -4.47%
SPPI -0.49%
SPRB 0.92%
SPRC 1.57%
SPRO -3.50%
SRNE -23.08%
SRPT 2.42%
SRRA 0.00%
SRRK 2.34%
SRZN -0.44%
STAB 0.00%
STOK -0.81%
STRO -1.28%
STSA 0.00%
STTK 2.41%
SURF -0.93%
SVRA -1.11%
SWTX 0.88%
SYBX 0.96%
SYRS 3.52%
TALS -0.73%
TARA -3.02%
TARS -0.78%
TBPH -0.58%
TCBP -3.57%
TCDA 0.00%
TCON -5.77%
TCRR 0.00%
TCRT 1.34%
TCRX 1.01%
TECH -1.03%
TENX -3.68%
TERN 3.40%
TFFP 8.24%
TGTX -0.30%
THRX 0.12%
TIL 0.00%
TLC 0.00%
TLSA -11.30%
TNGX 9.72%
TNXP -0.45%
TNYA -2.63%
TPST -0.97%
TRDA 1.45%
TRVI -2.46%
TRVN -2.95%
TSHA 5.37%
TSVT -4.06%
TTNP 6.44%
TVTX -2.93%
TYRA 3.19%
UBX -3.17%
UNCY -1.41%
URGN 42.15%
UTHR 1.11%
VACC 11.36%
VALN -12.14%
VAXX -5.36%
VBIV -4.90%
VBLT -8.77%
VCEL -1.25%
VCNX -0.58%
VCYT -2.13%
VERA -1.39%
VERU -0.99%
VERV -0.45%
VIGL -2.79%
VINC -5.45%
VIR -2.39%
VIRI -0.09%
VIRX 5.16%
VKTX -0.78%
VLON -13.04%
VNDA 10.05%
VOR -4.76%
VRCA 1.17%
VRDN 1.03%
VRNA 4.54%
VRPX 0.17%
VRTX 0.68%
VSTM 0.70%
VTGN -2.17%
VTVT 0.33%
VTYX -4.35%
VXRT -3.47%
VYGR 1.04%
VYNE -4.19%
VYNT 7.78%
WINT 0.00%
WVE -0.63%
XBIO 3.03%
XBIT -4.78%
XCUR -4.76%
XENE -0.77%
XERS -1.07%
XFOR -4.52%
XLO -0.44%
XLRN 0.00%
XNCR -2.27%
XOMA 5.96%
XOMAO -0.28%
XOMAP -0.20%
XRTX 8.36%
YMAB 0.33%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.70%
ZNTL -1.12%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-05 Yoshiyama Annie Sell 0 Common Stock
2024-06-05 Yoshiyama Annie Sell 348 708 Stock Option (Right to buy)
2024-06-05 Mayo Stephen Buy 191 082 Stock Option (Right to buy)
2024-06-05 Barrett Elizabeth A. Buy 191 082 Stock Option (Right to buy)
2024-06-05 Sato Vicki L Buy 61 475 Common Stock
INSIDER POWER
90.29
Last 94 transactions
Buy: 21 780 073 | Sell: 975 297
Correlation (AI algo v.1.1b): Undervalued: 8 090.44% $209.68 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.24 (neutral)
Short: -0.35 (neutral)
Signal:(37.266) Neutral

Allogene Therapeutics Inc Correlation

10 Most Positive Correlations
OZEM1
BKHAU0.95
BWIN0.942
NESRW0.929
CSX0.925
RENE0.923
ROST0.921
CPLSX0.917
ATMV0.913
JAJWX0.91
10 Most Negative Correlations
AIXI-0.946
RENB-0.944
ICUCW-0.941
OMH-0.933
RDZN-0.929
PAVS-0.929
ICU-0.927
INDV-0.926
INBS-0.925
CHNR-0.917

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Allogene Therapeutics Inc Correlation - Currency/Commodity

The country flag -0.15
( neutral )
The country flag -0.14
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.39
( neutral )

Allogene Therapeutics Inc Financials

Annual 2023
Revenue: $95 000.00
Gross Profit: $-242.82M (-255 598.95 %)
EPS: $-2.09
FY 2023
Revenue: $95 000.00
Gross Profit: $-242.82M (-255 598.95 %)
EPS: $-2.09
FY 2022
Revenue: $243 000
Gross Profit: $-16.49M (-6 783.95 %)
EPS: $-2.30
FY 2021
Revenue: $38.49M
Gross Profit: $0.00 (0.00 %)
EPS: $-2.14

Financial Reports:

No articles found.

Allogene Therapeutics Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Allogene Therapeutics Inc

Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell ALL. The company also develops ALLO-501, an anti-CD19 allogeneic CAR T cell product candidate that is in Phase I clinical trial for the treatment of R/R non-Hodgkin lymphoma; and ALLO-501A, which is in Phase I/II clinical trial for the treatment R/R large B-cell lymphoma or transformed follicular lymphoma. In addition, it is developing ALLO-715, an allogeneic CAR T cell product candidate that is in a Phase I clinical trial for treating R/R multiple myeloma; ALLO-605, an allogeneic CAR T cell product candidate for the treatment of multiple myeloma; ALLO-647, an anti-CD52 monoclonal antibody; CD70 to treat renal cell cancer; ALLO-819, an allogeneic CAR T cell product candidates for the treatment of acute myeloid leukemia; and DLL3 for the treatment of small cell lung cancer and other aggressive neuroendocrine tumors. The company has license and collaboration agreements with Pfizer Inc.; Servier; Cellectis S.A.; and Notch Therapeutics Inc., as well as clinical trial collaboration agreement with SpringWorks Therapeutics, Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates. The company was incorporated in 2017 and is headquartered in South San Francisco, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 2.2077798843384 seconds
Number of API calls: 3
Number of DB calls: 9